Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: A population-based study

BJU International

Volumn 116, Issue , 2015, Pages 18-25

  Patel, Manish I ^a   Bang, Albert ^b   Gillatt, David ^c   Smith, David P ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CANCER RESEARCH DIVISION   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

Author keywords

bladder cancer; cystectomy; population; survival; volume

Indexed keywords

ADULT; AGE; AGED; ARTICLE; AUSTRALIA; BLADDER CANCER; CANCER REGISTRY; CANCER STAGING; CONTROLLED STUDY; CYSTECTOMY; DISEASE SEVERITY; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; GENDER; HUMAN; LOG RANK TEST; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PERIOPERATIVE MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; BLADDER; DISEASE FREE SURVIVAL; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME; TUMOR INVASION; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEW SOUTH WALES; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84946480539     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.13152     Document Type: Article

References (41)

1. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-675
2. Dalbagni G, Genega E, Hashibe M, et al. Cystectomy for bladder cancer: a contemporary series. J Urol 2001; 165: 1111-1116
3. Colombo R, Pellucchi F, Moschini M, et al. Fifteen-year single-centre experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients. World J Urol 2015. [Epub ahead of print]. doi: 10.1007/s00345-015-1482-y
4. Bochner BH, Dalbagni G, Sjoberg DD, et al. Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur Urol 2014; 67: 1042-1050
5. Ahdoot M, Almario L, Araya H, Busch J, Conti S, Gonzalgo ML,. Oncologic outcomes between open and robotic-assisted radical cystectomy: a propensity score matched analysis. World J Urol 2014; 32: 1441-1446
6. Kluth LA, Rieken M, Xylinas E, et al. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. Eur Urol 2014; 66: 913-919
7. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006; 176: 2414-2422
8. Al-Daghmin A, Kauffman EC, Shi Y, et al. Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC). BJU Int 2014; 114: 98-103
9. Tracey E, Chen S, Baker D, Bishop J, Jelfs P,. Cancer in New South Wales. Incidence and Mortality Report 2004. Sydney: NSW Central Cancer Registry, Cancer Institute NSW, 2006. Available at: http://www.parliament.nsw.gov.au/Prod/la/latabdoc.nsf/0/397d15b521f325f4ca25722d00820f05/$FILE/incidence-mortality-report-2004.pdf. Accessed April 2015
10. Australian Bureau of Statistics. Census of Population and Housing. Socioeconomic Indexes for Areas, 1996. Canberra: Australian Bureau of Statistics, 1998. Availbale at: http://www.abs.gov.au/. Accessed April 2015
11. Commenwealth Department of Health and Aged Care. Measuring Remoteness: Accessibility/Remoteness Index of Australia (ARIA), 1999. Canberra: Commonwealth of Australia, 1999. Avaiable at: http://www.health.gov.au. Accessed April 2015
12. Esteban D, Whelan S, Laudico A, Parkin D,. Chapt. 4: coding. In, Esteban D, Whelan S, Laudico A, Parkin D, eds, Manual for Cancer Registry Personnel: IARC Technical Report No. 10, Lyon: International Agency for Research on Cancer, 1995: 1-18
13. Hollenbeck BK, Wei Y, Birkmeyer JD,. Volume, process of care, and operative mortality for cystectomy for bladder cancer. Urology 2007; 69: 871-875
14. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-1137
15. Booth CM, Siemens DR, Wei X, Peng Y, Berman DM, Mackillop WJ,. Pathological factors associated with survival benefit from adjuvant chemotherapy (ACT): a population-based study of bladder cancer. BJU Int 2014. [Epub ahead of print]. doi: 10.1111/bju.12913
16. Goossens-Laan CA, Leliveld AM, Verhoeven RH, et al. Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer. Int J Cancer 2014; 135: 905-912
17. Leliveld AM, Doornweerd BH, Bastiaannet E, Schaapveld M, de Jong IJ,. Treatment and outcome in muscle invasive bladder cancer: a population-based survey. World J Urol 2010; 28: 439-444
18. Sun M, Abdollah F, Bianchi M, et al. Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy. Eur J Cancer 2012; 48: 1503-1511
19. Munro NP, Sundaram SK, Weston PM, et al. A 10-year retrospective review of a nonrandomized cohort of 458 patients undergoing radical radiotherapy or cystectomy in Yorkshire, UK. Int J Radiat Oncol Biol Phys 2010; 77: 119-124
20. Millar JL, Frydenberg M, Toner G, et al. Management of muscle-invasive bladder cancer in Victoria, 1990-1995. ANZ J Surg 2006; 76: 113-119
21. Zehnder P, Studer UE, Skinner EC, et al. Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades. BJU Int 2013; 112: E51-58
22. Rink M, Ehdaie B, Cha EK, et al. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol 2012; 62: 677-684
23. Ploussard G, Shariat SF, Dragomir A, et al. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. Eur Urol 2014; 66: 361-370
24. National Cancer Institute. SEER stat fact sheets: bladder cancer, 2010. Available at: http://seer.cancer.gov/statfacts/html/urinb.html. Accessed April 2015
25. Sternberg CN, de Mulder P, Schornagel JH, et al. Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours. Eur J Cancer 2006; 42: 50-54
26. Tracey E, Watt H, Currow D, Young J, Armstrong B,. Investigation of poorer bladder cancer survival in women than men in NSW Australia: a data linkage study. BJU Int 2014; 113: 437-448
27. Mitra AP, Skinner EC, Schuckman AK, Quinn DI, Dorff TB, Daneshmand S,. Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients. Urol Oncol 2014; 32: 52 e1-529
28. Ahmadi N, Delprado WJ, Brooks AJ, et al. Pathological evaluation and quality of surgery in radical cystectomy in New South Wales, Australia. ANZ J Surg 2015; 85: 145-149
29. Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE,. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008; 179: 873-878
30. Fang AC, Ahmad AE, Whitson JM, Ferrell LD, Carroll PR, Konety BR,. Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer. Cancer 2010; 116: 1901-1908
31. Tilki D, Brausi M, Colombo R, et al. Lymphadenectomy for bladder cancer at the time of radical cystectomy. Eur Urol 2013; 64: 266-276
32. Rao K, Manya K, Azad A, et al. Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre-impact on clinical decision-making and implications for patient inclusion. BJU Int 2014; 114 (Suppl. 1): 50-54
33. Liew MS, Azad A, Tafreshi A, et al. USANZ: time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer. BJU Int 2013; 112 (Suppl. 2): 74-82
34. Novotny V, Hakenberg OW, Wiessner D, et al. Perioperative complications of radical cystectomy in a contemporary series. Eur Urol 2007; 51: 397-402
35. Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009; 55: 164-174
36. Konety BR, Allareddy V, Herr H,. Complications after radical cystectomy: analysis of population-based data. Urology 2006; 68: 58-64
37. Mayr R, May M, Martini T, et al. Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder. BJU Int 2012; 110: E222-227
38. Finks JF, Osborne NH, Birkmeyer JD,. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med 2011; 364: 2128-2137
39. Baade PD, Youlden DR, Coory MD, Gardiner RA, Chambers SK,. Urban-rural differences in prostate cancer outcomes in Australia: what has changed? Med J Aust 2011; 194: 293-296
40. Yu XQ, Luo Q, Smith DP, O'Connell DL, Baade PD,. Geographic variation in prostate cancer survival in New South Wales. Med J Aust 2014; 200: 586-590
41. Morgan TM, Barocas DA, Keegan KA, et al. Volume outcomes of cystectomy-is it the surgeon or the setting? J Urol 2012; 188: 2139-2144